Latest news
Takeda gains European backing for Shire acquisition
Takeda has reached the latest milestone for its £46 billion acquisition of Shire after gaining the approval of the European Commission following an investigation.
The...
Sobi secures US approval for HLH treatment Gamifant
Swedish Orphan Biovitrum (Sobi) has this week gained US approval for Gamifant (emapalumab-lzsg), the first and only treatment for haemophagocytic lymphohistiocytosis (HLH).
Primary HLH is...
EC approval for Lilly’s migraine treatment
Eli Lilly has gained European marketing authorisation for Emgality (galcanezumab) for the prophylaxis of migraine in adults who have at least four migraine days...
